Vitamin B6

Vitamin B6 is one of the B vitamins, and thus an essential nutrient.[1][2][3][4] The term refers to a group of six chemically similar compounds, i.e., "vitamers", which can be interconverted in biological systems. Its active form, pyridoxal 5′-phosphate, serves as a coenzyme in more than 140 enzyme reactions in amino acid, glucose, and lipid metabolism.[1][2][3]

This article is about the group of vitamers. For the dietary supplement, see Pyridoxine.

Vitamin B6
Drug class
Pyridoxal 5'-phosphate, the metabolically active form of vitamin B6
Class identifiers
UseVitamin B6 deficiency
ATC codeA11H
Biological targetenzyme cofactor
Clinical data
Drugs.comInternational Drug Names
External links
MeSHD025101
In Wikidata

Plants synthesize pyridoxine as a means of protection from the ultraviolet-B radiation of sunlight[5] and to participate in synthesis of chlorophyll.[6] Animals cannot synthesize any of the various forms of the vitamin, and hence must obtain it via diet, either of plants, or of other animals. There is some absorption of the vitamin produced by intestinal bacteria, but this is not sufficient to meet needs. For adult humans, recommendations from various countries' food regulatory agencies are in the range of 1.0 to 2.0 milligrams (mg) per day. These same agencies also recognize ill effects from intakes that are too high, and so set safe upper limits, ranging from as low as 25 mg/day to as high as 100 mg/day depending on the country. Beef, pork, fowl and fish are generally good sources; dairy, eggs, mollusks and crustaceans also contain vitamin B6, but at lower levels. There is enough in a wide variety of plant foods so that a vegetarian or vegan diet does not put consumers at risk for deficiency.[7]

Dietary deficiency is rare. Classic clinical symptoms include rash and inflammation around the mouth and eyes, plus neurological effects that include drowsiness and peripheral neuropathy affecting sensory and motor nerves in the hands and feet. In addition to dietary shortfall, deficiency can be the result of anti-vitamin drugs. There are also rare genetic defects that can trigger vitamin B6 deficiency-dependent epileptic seizures in infants. These are responsive to pyridoxal 5'-phosphate therapy.[8]

Definition
Pyridoxine (PN)
Pyridoxamine (PM)
Pyridoxal (PL)

Vitamin B6 is a water-soluble vitamin, one of the B vitamins. The vitamin actually comprises a group of six chemically related compounds, i.e., vitamers, that all contain a pyridine ring as their core. These are pyridoxine, pyridoxal, pyridoxamine, and their respective phosphorylated derivatives pyridoxine 5'-phosphate, pyridoxal 5'-phosphate and pyridoxamine 5'-phosphate. Pyridoxal 5'-phosphate has the highest biological activity, but the others are convertible to that form.[9] Vitamin B6 serves as a co-factor in more than 140 cellular reactions, mostly related to amino acid biosynthesis and catabolism, but is also involved in fatty acid biosynthesis and other physiological functions.[1][2][3]

Forms

Because of its chemical stability, pyridoxine hydrochloride is the form most commonly given as vitamin B6 dietary supplement. Absorbed pyridoxine (PN) is converted to pyridoxamine 5'-phosphate (PMP) by the enzyme pyridoxal kinase, with PMP further converted to pyridoxal 5'-phosphate (PLP), the metabolically active form, by the enzymes pyridoxamine-phosphate transaminase or pyridoxine 5'-phosphate oxidase, the latter of which also catalyzes the conversion of pyridoxine 5′-phosphate (PNP) to PLP.[3][9] Pyridoxine 5'-phosphate oxidase is dependent on flavin mononucleotide (FMN) as a cofactor produced from riboflavin (vitamin B2). For degradation, in a non-reversible reaction, PLP is catabolized to 4-pyridoxic acid, which is excreted in urine.[3]

Synthesis

Biosynthesis

Two pathways for PLP are currently known: one requires deoxyxylulose 5-phosphate (DXP), while the other does not, hence they are known as DXP-dependent and DXP-independent. These pathways have been studied extensively in Escherichia coli[10] and Bacillus subtilis, respectively. Despite the disparity in the starting compounds and the different number of steps required, the two pathways possess many commonalities.[11] The DXP-dependent pathway:

Commercial synthesis

The starting material is either the amino acid alanine, or propionic acid converted into alanine via halogenation and amination. Then, the procedure accomplishes the conversion of the amino acid into pyridoxine through the formation of an oxazole intermediate followed by a Diels–Alder reaction, with the entire process referred to as the "oxazole method".[9][12] The product used in dietary supplements and food fortification is pyridoxine hydrochloride, the chemically stable hydrochloride salt of pyridoxine.[13] Pyridoxine is converted in the liver into the metabolically active coenzyme form pyridoxal 5'-phosphate. At present, while the industry mainly utilizes the oxazole method, there is research exploring means of using less toxic and dangerous reagents in the process.[14] Fermentative bacterial biosynthesis methods are also being explored, but are not yet scaled up for commercial production.[13]

Functions

PLP is involved in many aspects of macronutrient metabolism, neurotransmitter synthesis, histamine synthesis, hemoglobin synthesis and function, and gene expression. PLP generally serves as a coenzyme (cofactor) for many reactions including decarboxylation, transamination, racemization, elimination, replacement, and beta-group interconversion.[2][3][15]

Amino acid metabolism
  1. Transaminases break down amino acids with PLP as a cofactor. The proper activity of these enzymes is crucial for the process of moving amine groups from one amino acid to another. To function as a transaminase coenzyme, PLP bound to a lysine of the enzyme then binds to a free amino acid via formation of a Schiff's base. The process then dissociates the amine group from the amino acid, releasing a keto acid, then transfers the amine group to a different keto acid to create a new amino acid.[3]
  2. Serine racemase which synthesizes the neuromodulator D-serine from its enantiomer is a PLP-dependent enzyme.
  3. PLP is a coenzyme needed for the proper function of the enzymes cystathionine synthase and cystathionase. These enzymes catalyze reactions in the catabolism of methionine. Part of this pathway (the reaction catalyzed by cystathionase) also produces cysteine.
  4. Selenomethionine is the primary dietary form of selenium. PLP is needed as a cofactor for the enzymes that allow selenium to be used from the dietary form. PLP also plays a cofactor role in releasing selenium from selenohomocysteine to produce hydrogen selenide, which can then be used to incorporate selenium into selenoproteins.
  5. PLP is required for the conversion of tryptophan to niacin, so low vitamin B6 status impairs this conversion.[15]

Neurotransmitters
  1. PLP is a cofactor in the biosynthesis of five important neurotransmitters: serotonin, dopamine, epinephrine, norepinephrine, and gamma-aminobutyric acid.[6]

Glucose metabolism

PLP is a required coenzyme of glycogen phosphorylase, the enzyme necessary for glycogenolysis. Glycogen serves as a carbohydrate storage molecule, primarily found in muscle, liver and brain. Its breakdown frees up glucose for energy.[6] PLP also catalyzes transamination reactions that are essential for providing amino acids as a substrate for gluconeogenesis, the biosynthesis of glucose.[15]

Lipid metabolism

PLP is an essential component of enzymes that facilitate the biosynthesis of sphingolipids.[15] Particularly, the synthesis of ceramide requires PLP. In this reaction, serine is decarboxylated and combined with palmitoyl-CoA to form sphinganine, which is combined with a fatty acyl-CoA to form dihydroceramide. This compound is then further desaturated to form ceramide. In addition, the breakdown of sphingolipids is also dependent on vitamin B6 because sphingosine-1-phosphate lyase, the enzyme responsible for breaking down sphingosine-1-phosphate, is also PLP-dependent.

Hemoglobin synthesis and function

PLP aids in the synthesis of hemoglobin, by serving as a coenzyme for the enzyme aminolevulinic acid synthase.[6] It also binds to two sites on hemoglobin to enhance the oxygen binding of hemoglobin.[15]

Gene expression

PLP has been implicated in increasing or decreasing the expression of certain genes. Increased intracellular levels of the vitamin lead to a decrease in the transcription of glucocorticoids. Vitamin B6 deficiency leads to the increased gene expression of albumin mRNA. Also, PLP influences expression of glycoprotein IIb by interacting with various transcription factors; the result is inhibition of platelet aggregation.[15]

In plants

Plant synthesis of vitamin B6 contributes to protection from sunlight. Ultraviolet-B radiation (UV-B) from sunlight stimulates plant growth, but in high amounts can increase production of tissue-damaging reactive oxygen species (ROS), i.e., oxidants. Using Arabidopsis thaliana (common name: thale cress), researchers demonstrated that UV-B exposure increased pyridoxine biosynthesis, but in a mutant variety, pyridoxine biosynthesis capacity was not inducible, and as a consequence, ROS levels, lipid peroxidation, and cell proteins associated with tissue damage were all elevated.[5][16][17] Biosynthesis of chlorophyll depends on aminolevulinic acid synthase, a PLP-dependent enzyme that uses succinyl-CoA and glycine to generate aminolevulinic acid, a chlorophyll precursor.[6] In addition, plant mutants with severely limited capacity to synthesize vitamin B6 have stunted root growth, because synthesis of plant hormones such as auxin require the vitamin as an enzyme cofactor.[6]

Medical uses
Further information: Pyridoxine

Isoniazid is an antibiotic used for the treatment of tuberculosis. Common side effect include numbness in the hands and feet, also known as peripheral neuropathy.[18] Co-treatment with vitamin B6 alleviates the numbness.[19]

Overconsumption of seeds from Ginkgo biloba can deplete vitamin B6, because the ginkgotoxin is an anti-vitamin (vitamin antagonist). Symptoms include vomiting and generalized convulsions. Ginkgo seed poisoning can be treated with vitamin B6.[20][21]

Dietary recommendations

The US National Academy of Medicine updated Dietary Reference Intakes for many vitamins in 1998. Recommended Dietary Allowances (RDAs), expressed as milligrams per day, increase with age from 1.2 to 1.5 mg/day for women and from 1.3 to 1.7 mg/day for men. The RDA for pregnancy is 1.9 mg/day, for lactation, 2.0 mg/day. For children ages 1–13 years the RDA increases with age from 0.5 to 1.0 mg/day. As for safety, Tolerable upper intake levels (ULs) for vitamins and minerals are identified when evidence is sufficient. In the case of vitamin B6 the adult UL is set at 100 mg/day.[4]

The European Food Safety Authority (EFSA) refers to the collective set of information as Dietary Reference Values, with Population Reference Intake (PRI) instead of RDA. For women and men ages 15 and older the PRI is set at 1.6 and 1.7 mg/day, respectively; for pregnancy 1.8 mg/day, for lactation 1.7 mg/day. For children ages 1–14 years the PRIs increase with age from 0.6 to 1.4 mg/day.[22] The EFSA also reviewed the safety question and set its UL at 25 mg/day.[23][24]

The Japanese Ministry of Health, Labour and Welfare updated its vitamin and mineral recommendations in 2015. The adult RDAs are at 1.2 mg/day for women 1.4 mg/day for men. The RDA for pregnancy is 1.4 mg/day, for lactation is 1.5 mg/day. For children ages 1–17 years the RDA increases with age from 0.5 to 1.5 mg/day. The adult UL was set at 40–45 mg/day for women and 50–60 mg/day for men, with the lower values in those ranges for adults over 70 years of age.[25]

Safety
Main article: Megavitamin-B6 syndrome

Adverse effects have been documented from vitamin B6 dietary supplements, but never from food sources. Even though it is a water-soluble vitamin and is excreted in the urine, doses of pyridoxine in excess of the dietary upper limit (UL) over long periods cause painful and ultimately irreversible neurological problems.[4] The primary symptoms are pain and numbness of the extremities. In severe cases, motor neuropathy may occur with "slowing of motor conduction velocities, prolonged F wave latencies, and prolonged sensory latencies in both lower extremities", causing difficulty in walking. Sensory neuropathy typically develops at doses of pyridoxine in excess of 1,000 mg per day, but adverse effects can occur with much less, so intakes over 200 mg/day are not considered safe.[4] Trials with amounts equal to or less than 200 mg/day established that as a "No-observed-adverse-effect level", meaning the highest amount at which no adverse effects were observed. This was divided by two to allow for people who might be extra sensitive to the vitamin, referred to as an "uncertainty factor", resulting in the aforementioned adult UL of 100 mg/day.[4]

Labeling

For US food and dietary supplement labeling purposes the amount in a serving is expressed as a percent of Daily Value. For vitamin B6 labeling purposes 100% of the Daily Value was 2.0 mg, but as of May 27, 2016 it was revised to 1.7 mg to bring it into agreement with the adult RDA.[26][27] A table of the old and new adult daily values is provided at Reference Daily Intake.

Sources

Bacteria residing in the large intestine are known to synthesize B-vitamins, including B6, but the amounts are not sufficient to meet host requirements, in part because the vitamins are competitively taken up by non-synthesizing bacteria.[28]

Vitamin B6 is found in a wide variety of foods. In general, meat, fish and fowl are good sources, but dairy foods and eggs are not (table).[29][30] Crustaceans and mollusks contain about 0.1 mg/100 grams. Fruit (apples, oranges, pears) contain less than 0.1 mg/100g.[30]

Bioavailability from a mixed diet (containing animal- and plant-sourced foods) is estimated at being 75% – higher for PLP from meat, fish and fowl, lower from plants, as those are mostly in the form of pyridoxine glucoside, which has approximately half the bioavailability of animal-sourced B6 because removal of the glucoside by intestinal cells is not 100% efficient.[4] Given lower amounts and lower bioavailability of the vitamin from plants there was a concern that a vegetarian or vegan diet could cause a vitamin deficiency state. However, the results from a population-based survey conducted in the U.S. demonstrated that despite a lower vitamin intake, serum PLP was not significantly different between meat-eaters and vegetarians, suggesting that a vegetarian diet does not pose a risk for vitamin B6 deficiency.[7]

Cooking, storage, and processing losses vary, and in some foods may be more than 50% depending on the form of vitamin present in the food.[3] Plant foods lose less during processing, as they contain pyridoxine, which is more stable than the pyridoxal or pyridoxamine forms found in animal-sourced foods. For example, milk can lose 30–70% of its vitamin B6 content when dried.[15] The vitamin is found in the germ and aleurone layer of grains, so there is more in whole wheat bread compared to white bread wheat, and more in brown rice compared to white rice.[30]

Most values shown in the table are rounded to nearest tenth of a milligram:

Source[29][30] Amount
(mg per 100 grams)
Whey protein concentrate1.2
Beef liver, pan-fried1.0
Tuna, skipjack, cooked1.0
Beef steak, grilled0.9
Salmon, Atlantic, cooked0.9
Chicken breast, grilled0.7
Pork chop, cooked0.6
Turkey, ground, cooked0.6
Banana0.4
Source[29][30] Amount
(mg per 100 grams)
Mushroom, Shiitake, raw0.3
Potato, baked, with skin0.3
Sweet potato baked0.3
Bell pepper, red0.3
Peanuts0.3
Avocado0.25
Spinach0.2
Chickpeas0.1
Tofu, firm0.1
Source[30] Amount
(mg per 100 grams)
Corn grits0.1
Milk, whole0.1 (one cup)
Yogurt0.1 (one cup)
Almonds0.1
Bread, whole wheat/white0.2/0.1
Rice, cooked, brown/white0.15/0.02
Beans, baked0.1
Beans, green0.1
Chicken egg0.1

Fortification

As of 2019, fourteen countries require food fortification of wheat flour, maize flour or rice with vitamin B6 as pyridoxine hydrochloride. Most of these are in southeast Africa or Central America. The amounts stipulated range from 3.0 to 6.5 mg/kg. An additional seven countries, including India, have a voluntary fortification program. India stipulates 2.0 mg/kg.[31]

Dietary supplements

In the US, multi-vitamin/mineral products typically contain 2 to 4 mg of vitamin B6 per daily serving as pyridoxine hydrochloride, but a few contain more than 25 mg. Many US dietary supplement companies also market a B6-only dietary supplement with 100 mg per daily serving.[1] While the US National Academy of Medicine sets an adult safety UL at 100 mg/day,[1][4] the European Food Safety Authority sets its UL at 25 mg/day.[23][24]

Health claims

The Japanese Ministry of Health, Labour, and Welfare (MHLW) set up the 'Foods for Specified Health Uses' (特定保健用食品; FOSHU) regulatory system in 1991 to individually approve the statements made on food labels concerning the effects of foods on the human body. The regulatory range of FOSHU was later broadened to allow for the certification of capsules and tablets. In 2001, MHLW enacted a new regulatory system, 'Foods with Health Claims' (保健機能食品; FHC), which consists of the existing FOSHU system and the newly established 'Foods with Nutrient Function Claims' (栄養機能表示食品; FNFC), under which claims were approved for any product containing a specified amount per serving of 12 vitamins, including vitamin B6, and two minerals.[32][33] To make a health claim based on a food's vitamin B6 content, the amount per serving must be in the range of 0.3–25 mg. The allowed claim is: "Vitamin B6 is a nutrient that helps produce energy from protein and helps maintain healthy skin and mucous membranes."[34][35]

In 2010, the European Food Safety Authority (EFSA) published a review of proposed health claims for vitamin B6, disallowing claims for bone, teeth, hair skin and nails, and allowing claims that the vitamin provided for normal homocysteine metabolism, normal energy-yielding metabolism, normal psychological function, reduced tiredness and fatigue, and provided for normal cysteine synthesis.[36]

The US Food and Drug Administration (FDA) has several processes for permitting health claims on food and dietary supplement labels.[37] There are no FDA-approved Health Claims or Qualified Health Claims for vitamin B6. Structure/Function Claims can be made without FDA review or approval as long as there is some credible supporting science.[37] Examples for this vitamin are "Helps support nervous system function" and "Supports healthy homocysteine metabolism."

Absorption, metabolism and excretion

Vitamin B6 is absorbed in the jejunum of the small intestine by passive diffusion.[1][4] Even extremely large amounts are well absorbed. Absorption of the phosphate forms involves their dephosphorylation catalyzed by the enzyme alkaline phosphatase.[15] Most of the vitamin is taken up by the liver. There, the dephosphorylated vitamins are converted to the phosphorylated PLP, PNP and PMP, with the two latter converted to PLP. In the liver, PLP is bound to proteins, primarily albumin. The PLP-albumin complex is what is released by the liver to circulate in plasma.[4] Protein-binding capacity is the limiting factor for vitamin storage. Total body stores, the majority in muscle, with a lesser amount in liver, have been estimated to be in the range of 61 to 167 mg.[4]

Enzymatic processes utilize PLP as a phosphate-donating cofactor. PLP is restored via a salvage pathway that requires three key enzymes, pyridoxal kinase, pyridoxine 5'-phosphate oxidase, and phosphatases.[6][8] Inborn errors in the salvage enzymes are known to cause inadequate levels of PLP in the cell, particularly in neuronal cells. The resulting PLP deficiency is known to cause or implicated in several pathologies, most notably infant epileptic seizures.[8]

The end-product of vitamin B6 catabolism is 4-pyridoxic acid, which makes up about half of the B6 compounds in urine. 4-Pyridoxic acid is formed by the action of aldehyde oxidase in the liver. Amounts excreted increase within 1–2 weeks with vitamin supplementation and decrease as rapidly after supplementation ceases.[4][38] Other vitamin forms excreted in the urine include pyridoxal, pyridoxamine and pyridoxine, and their phosphates. When large doses of pyridoxine are given orally, the proportion of these other forms increases. A small amount of vitamin B6 is also excreted in the feces. This may be a combination of unabsorbed vitamin and what was synthesized by large intestine microbiota.[4]

Deficiency

Signs and symptoms

The classic clinical syndrome for vitamin B6 deficiency is a seborrhoeic dermatitis-like eruption, atrophic glossitis with ulceration, angular cheilitis, conjunctivitis, intertrigo, and neurologic symptoms of somnolence, confusion, and neuropathy (due to impaired sphingosine synthesis) and microcytic anemia (due to impaired heme synthesis).[1]

Less severe cases present with metabolic disease associated with insufficient activity of the coenzyme PLP. The most prominent of the lesions is due to impaired tryptophan–niacin conversion. This can be detected based on urinary excretion of xanthurenic acid after an oral tryptophan load. Vitamin B6 deficiency can also result in impaired transsulfuration of methionine to cysteine. The PLP-dependent transaminases and glycogen phosphorylase provide the vitamin with its role in gluconeogenesis, so deprivation of vitamin B6 results in impaired glucose tolerance.[15]

Diagnosis

The assessment of vitamin B6 status is essential, as the clinical signs and symptoms in less severe cases are not specific.[39] The three biochemical tests most widely used are plasma PLP concentrations, the activation coefficient for the erythrocyte enzyme aspartate aminotransferase, and the urinary excretion of vitamin B6 degradation products, specifically urinary PA. Of these, plasma PLP is probably the best single measure, because it reflects tissue stores. Plasma PLP of less than 10 nmol/L is indicative of vitamin B6 deficiency.[38] A PLP concentration greater than 20 nmol/L has been chosen as a level of adequacy for establishing Estimated Average Requirements and Recommended Daily Allowances in the USA.[4] Urinary PA is also an indicator of vitamin B6 deficiency; levels of less than 3.0 mmol/day is suggestive of vitamin B6 deficiency.[38] Other methods of measurement, including UV spectrometric, spectrofluorimetric, mass spectrometric, thin-layer and high-performance liquid chromatographic, electrophoretic, electrochemical, and enzymatic, have been developed.[38][40]

The classic clinical symptoms for vitamin B6 deficiency are rare, even in developing countries. A handful of cases were seen between 1952 and 1953, particularly in the United States, having occurred in a small percentage of infants who were fed a formula lacking in pyridoxine.[41]

Causes

A deficiency of vitamin B6 alone is relatively uncommon and often occurs in association with other vitamins of the B complex. Evidence exists for decreased levels of vitamin B6 in women with type 1 diabetes and in patients with systemic inflammation, liver disease, rheumatoid arthritis, and those infected with HIV.[42][43] Use of oral contraceptives and treatment with certain anticonvulsants, isoniazid, cycloserine, penicillamine, and hydrocortisone negatively impact vitamin B6 status.[1][44][45] Hemodialysis reduces vitamin B6 plasma levels.[46]

Genetic defects

Genetically confirmed diagnoses of diseases affecting vitamin B6 metabolism (ALDH7A1 deficiency, pyridoxine-5'-phosphate oxidase deficiency, PLP binding protein deficiency, hyperprolinaemia type II and hypophosphatasia) can trigger vitamin B6 deficiency-dependent epileptic seizures in infants. These are responsive to pyridoxal 5'-phosphate therapy.[8][47]

History
Further information: Vitamin § History

An overview of the history was published in 2012.[48] In 1934, the Hungarian physician Paul György discovered a substance that was able to cure a skin disease in rats (dermatitis acrodynia). He named this substance vitamin B6, as numbering of the B vitamins was chronological, and pantothenic acid had been assigned vitamin B5 in 1931.[49][50] In 1938, Richard Kuhn was awarded the Nobel Prize in Chemistry for his work on carotenoids and vitamins, specifically B2 and B6.[51] Also in 1938, Samuel Lepkovsky isolated vitamin B6 from rice bran.[48] A year later, Stanton A. Harris and Karl August Folkers determined the structure of pyridoxine and reported success in chemical synthesis,[52] and then in 1942 Esmond Emerson Snell developed a microbiological growth assay that led to the characterization of pyridoxamine, the aminated product of pyridoxine, and pyridoxal, the formyl derivative of pyridoxine.[48] Further studies showed that pyridoxal, pyridoxamine, and pyridoxine have largely equal activity in animals and owe their vitamin activity to the ability of the organism to convert them into the enzymatically active form pyridoxal-5-phosphate.[48]

Following a recommendation of IUPAC-IUB in 1973,[53] vitamin B6 is the official name for all 2-methyl,3-hydroxy,5-hydroxymethylpyridine derivatives exhibiting the biological activity of pyridoxine.[54] Moreover, pyridoxine alone should not to be used as a synonym of vitamin B6.

Research

Observational studies suggested an inverse correlation between a higher intake of vitamin B6 and all cancers, with the strongest evidence for gastrointestinal cancers. However, evidence from a review of randomized clinical trials did not support a protective effect. The authors noted that high B6 intake may be an indicator of higher consumption of other dietary protective micronutrients.[55] A review and two observational trials reporting lung cancer risk reported that serum vitamin B6 was lower in people with lung cancer compared to people without lung cancer, but did not incorporate any intervention or prevention trials.[56][57][58]

According to a prospective cohort study the long-term use of vitamin B6 from individual supplement sources at greater than 20 mg per day, which is more than ten times the adult male RDA of 1.7 mg/day, was associated with an increased risk for lung cancer among men. Smoking further elevated this risk.[59] However, a more recent review of this study suggested that a causal relationship between supplemental vitamin B6 and an increased lung cancer risk cannot be confirmed yet.[60]

For coronary heart disease, a meta-analysis reported lower relative risk for a 0.5 mg/day increment in dietary vitamin B6 intake.[61] As of 2021, there were no published reviews of randomized clinical trials for coronary heart disease or cardiovascular disease. In reviews of observational and intervention trials, neither higher vitamin B6 concentrations[62] nor treatment[63] showed any significant benefit on cognition and dementia risk. Low dietary vitamin B6 correlated with a higher risk of depression in women but not in men.[64] When treatment trials were reviewed, no meaningful treatment effect for depression was reported, but a subset of trials in pre-menopausal women suggested a benefit, with a recommendation that more research was needed.[65] The results of several trials with children diagnosed as having autism spectrum disorder (ASD) treated with high dose vitamin B6 and magnesium did not result in treatment effect on the severity of symptoms of ASD.[66]

References
  1. "Facts about Vitamin B6 Fact Sheet for Health Professionals". Office of Dietary Supplements at National Institutes of Health. 24 February 2020. Retrieved 5 February 2021.
  2. "Vitamin B6". Micronutrient Information Center, Linus Pauling Institute, Oregon State University, Corvallis, OR. May 2014. Archived from the original on 2018-03-14. Retrieved 7 March 2017.
  3. Da Silva VR, Gregory III JF (2020). "Vitamin B6". In BP Marriott, DF Birt, VA Stallings, AA Yates (eds.). Present Knowledge in Nutrition, Eleventh Edition. London, United Kingdom: Academic Press (Elsevier). pp. 225–38. ISBN 978-0-323-66162-1.
  4. Institute of Medicine (1998). "Vitamin B6". Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: The National Academies Press. pp. 150–195. doi:10.17226/6015. ISBN 978-0-309-06554-2. LCCN 00028380. OCLC 475527045. PMID 23193625.
  5. Havaux M, Ksas B, Szewczyk A, Rumeau D, Franck F, Caffarri S, Triantaphylidès C (November 2009). "Vitamin B6 deficient plants display increased sensitivity to high light and photo-oxidative stress". BMC Plant Biol. 9: 130. doi:10.1186/1471-2229-9-130. PMC 2777905. PMID 19903353.
  6. Parra M, Stahl S, Hellmann H (July 2018). "Vitamin B6 and Its Role in Cell Metabolism and Physiology". Cells. 7 (7): 84. doi:10.3390/cells7070084. PMC 6071262. PMID 30037155.
  7. Schorgg P, Bärnighausen T, Rohrmann S, Cassidy A, Karavasiloglou N, Kühn T (May 2021). "Vitamin B6 Status among Vegetarians: Findings from a Population-Based Survey". Nutrients. 13 (5): 1627. doi:10.3390/nu13051627. PMC 8150266. PMID 34066199.
  8. Ghatge MS, Al Mughram M, Omar AM, Safo MK (April 2021). "Inborn errors in the vitamin B6 salvage enzymes associated with neonatal epileptic encephalopathy and other pathologies". Biochimie. 183: 18–29. doi:10.1016/j.biochi.2020.12.025. PMID 33421502. S2CID 231437416.
  9. Bachmann T, Rychlik M (August 2018). "Synthesis of [13C₃]-B6 Vitamers Labelled at Three Consecutive Positions Starting from [13C₃]-Propionic Acid". Molecules. 23 (9). doi:10.3390/molecules23092117. PMC 6225105. PMID 30142892.
  10. Tambasco-Studart M, Titiz O, Raschle T, Forster G, Amrhein N, Fitzpatrick TB (September 2005). "Vitamin B6 biosynthesis in higher plants". Proc Natl Acad Sci U S A. 102 (38): 13687–92. Bibcode:2005PNAS..10213687T. doi:10.1073/pnas.0506228102. PMC 1224648. PMID 16157873.
  11. Fitzpatrick TB, Amrhein N, Kappes B, Macheroux P, Tews I, Raschle T (October 2007). "Two independent routes of de novo vitamin B6 biosynthesis: not that different after all". The Biochemical Journal. 407 (1): 1–13. doi:10.1042/BJ20070765. PMC 2267407. PMID 17822383. S2CID 28231094.
  12. Eggersdorfer, Manfred; Laudert, Dietmar; Létinois, Ulla; McClymont, Tom; Medlock, Jonathan; Netscher, Thomas; Bonrath, Werner (2012). "One Hundred Years of Vitamins-A Success Story of the Natural Sciences". Angewandte Chemie International Edition. 51 (52): 12973–12974. doi:10.1002/anie.201205886. PMID 23208776.
  13. Wang Y, Liu L, Jin Z, Zhang D (2021). "Microbial Cell Factories for Green Production of Vitamins". Front Bioeng Biotechnol. 9: 661562. doi:10.3389/fbioe.2021.661562. PMC 8247775. PMID 34222212.
  14. Zou E, Shi X, Zhang G, Li Z, Jin C, Su W (November 2013). "Improved "Oxazole" Method for the Practical and Efficient Preparation of Pyridoxine Hydrochloride (Vitamin B6)". Org Process Res Dev. 17 (12): 1498–502. doi:10.1021/op4001687.
  15. Combs GF (2007). The Vitamins: Fundamental Aspects in Nutrition and Health (3rd ed.). San Diego: Elsevier Academic Press. pp. 320–324. ISBN 978-0-8121-0661-9. LCCN 2007026776. OCLC 150255807.
  16. Ristilä M, Strid H, Eriksson LA, Strid A, Sävenstrand H (March 2011). "The role of the pyridoxine (vitamin B6) biosynthesis enzyme PDX1 in ultraviolet-B radiation responses in plants". Plant Physiol Biochem. 49 (3): 284–92. doi:10.1016/j.plaphy.2011.01.003. PMID 21288732.
  17. Czégény G, Kőrösi L, Strid A, Hideg E (February 2019). "Multiple roles for Vitamin B6 in plant acclimation to UV-B". Scientific Reports. 9 (1): 1259. Bibcode:2019NatSR...9.1259C. doi:10.1038/s41598-018-38053-w. PMC 6361899. PMID 30718682.
  18. "Isoniazid". The American Society of Health-System Pharmacists. Retrieved 13 August 2021.
  19. Lheureux P, Penaloza A, Gris M (April 2005). "Pyridoxine in clinical toxicology: a review". Eur J Emerg Med. 12 (2): 78–85. doi:10.1097/00063110-200504000-00007. PMID 15756083. S2CID 39197646.
  20. Mei N, Guo X, Ren Z, Kobayashi D, Wada K, Guo L (January 2017). "Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports". J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 35 (1): 1–28. doi:10.1080/10590501.2016.1278298. PMC 6373469. PMID 28055331.
  21. Kobayashi D (2019). "[Food Poisoning by Ginkgo Seeds through Vitamin B6 Depletion]". Yakugaku Zasshi (in Japanese). 139 (1): 1–6. doi:10.1248/yakushi.18-00136. PMID 30606915.
  22. "Overview on Dietary Reference Values for the EU population as derived by the EFSA Panel on Dietetic Products, Nutrition and Allergies" (PDF). 2017. Archived (PDF) from the original on 2017-08-28.
  23. "Tolerable Upper Intake Levels For Vitamins And Minerals" (PDF). European Food Safety Authority. 2006. Archived (PDF) from the original on 19 September 2019.
  24. Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (2008). "Opinion on Pyridoxal 5′-phosphate as a source for vitamin B6 added for nutritional purposes in food supplements". The EFSA Journal. 760: 1–13. doi:10.2903/j.efsa.2008.760.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  25. "Overview of Dietary Reference Intakes for Japanese" (PDF). Ministry of Health, Labour and Welfare (Japan). 2015. Retrieved 19 August 2021.
  26. "Federal Register May 27, 2016 Food Labeling: Revision of the Nutrition and Supplement Facts Labels" (PDF). Archived (PDF) from the original on 2017-09-22.
  27. "Daily Value Reference of the Dietary Supplement Label Database (DSLD)". Dietary Supplement Label Database (DSLD). Archived from the original on 7 April 2020. Retrieved 16 May 2020.
  28. Mayengbam S, Chleilat F, Reimer RA (November 2020). "Dietary Vitamin B6 Deficiency Impairs Gut Microbiota and Host and Microbial Metabolites in Rats". Biomedicines. 8 (11): 469. doi:10.3390/biomedicines8110469. PMC 7693528. PMID 33147768.
  29. Joseph, Michael (10 January 2021). "30 Foods High In Vitamin B6". Nutrition Advance. Retrieved 17 August 2021. All nutritional values within this article have been sourced from the USDA's FoodData Central Database.
  30. "USDA Food Data Central. Standard Reference, Legacy Foods". USDA Food Data Central. April 2018. Retrieved 18 August 2021.
  31. "Map: Count of Nutrients In Fortification Standards". Global Fortification Data Exchange. 16 August 2021. Retrieved 16 August 2021.{{cite web}}: CS1 maint: url-status (link)
  32. Shimizu T (December 2003). "Health claims on functional foods: the Japanese regulations and an international comparison". Nutr Res Rev. 16 (2): 241–52. doi:10.1079/NRR200363. PMID 19087392.
  33. Harada K (2016). "食品中の機能性成分解析" [Analysis of Functional Ingredients in Foods]. Bunseki Kagaku (in Japanese). The Japan Society for Analytical Chemistry. 65 (6): 309–319. doi:10.2116/bunsekikagaku.65.309. ISSN 0525-1931.
  34. Shimizu T (2001). "新しい保健機能性食晶制度の概要" [Newly Established Regulation: Foods with Health Claims] (PDF). Journal of the International Life Sciences Institute of Japan (in Japanese). 66: 9–15.
  35. "(問14) 栄養機能食品の規格基準及び表示の基準とは、どのようなものか" [Question 14—What are the standards and labeling criteria for Foods with Nutrient Function Claims?]. Ministry of Health, Labour, and Welfare (in Japanese). Retrieved 2021-09-23. ビタミンＢ６は、たんぱく質からのエネルギー産生と皮膚や粘膜の健康維持を助ける栄養素です。{{cite web}}: CS1 maint: url-status (link)
  36. "Scientific Opinion on the substantiation of health claims related to vitamin B6". EFSA Journal. 8 (10): 1759. 2010. doi:10.2903/j.efsa.2010.1759.
  37. "Label Claims for Conventional Foods and Dietary Supplements". U.S. Food and Drug Administration. 19 June 2018. Retrieved 17 August 2021.
  38. Ueland PM, Ulvik A, Rios-Avila L, Midttun Ø, Gregory JF (2015). "Direct and Functional Biomarkers of Vitamin B6 Status". Annu Rev Nutr. 35: 33–70. doi:10.1146/annurev-nutr-071714-034330. PMC 5988249. PMID 25974692.
  39. Gibson RS (2005). "Assessment of vitamin B6 status". Principles of Nutritional Assessment (2nd ed.). New York: Oxford University Press. pp. 575–594. ISBN 978-0-19-517169-3. LCCN 2004054778. OCLC 884490740.
  40. Ahmad I, Mirza T, Qadeer K, Nazim U, Vaid FH (September 2013). "Vitamin B6: deficiency diseases and methods of analysis". Pak J Pharm Sci. 26 (5): 1057–69. PMID 24035968.
  41. Menkes JH (1980). Textbook of Child Neurology (2nd ed.). Philadelphia: Henry Kimpton Publishers. p. 486. ISBN 978-0-8121-0661-9. LCCN 79010975. OCLC 925196268.
  42. Massé PG, Boudreau J, Tranchant CC, Ouellette R, Ericson KL (February 2012). "Type 1 diabetes impairs vitamin B(6) metabolism at an early stage of women's adulthood". Applied Physiology, Nutrition, and Metabolism. 37 (1): 167–75. doi:10.1139/h11-146. PMID 22288928.
  43. Ulvik A, Midttun Ø, Pedersen ER, Eussen SJ, Nygård O, Ueland PM (July 2014). "Evidence for increased catabolism of vitamin B-6 during systemic inflammation". The American Journal of Clinical Nutrition. 100 (1): 250–5. doi:10.3945/ajcn.114.083196. PMID 24808485.
  44. Wilson SM, Bivins BN, Russell KA, Bailey LB (October 2011). "Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status". Nutrition Reviews. 69 (10): 572–83. doi:10.1111/j.1753-4887.2011.00419.x. PMID 21967158.
  45. Schwaninger M, Ringleb P, Winter R, Kohl B, Fiehn W, Rieser PA, Walter-Sack I (March 1999). "Elevated plasma concentrations of homocysteine in antiepileptic drug treatment". Epilepsia. 40 (3): 345–50. doi:10.1111/j.1528-1157.1999.tb00716.x. PMID 10080517.
  46. Corken M, Porter J (September 2011). "Is vitamin B(6) deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000-2010". Nephrology. 16 (7): 619–25. doi:10.1111/j.1440-1797.2011.01479.x. PMID 21609363. S2CID 22894817.
  47. Mastrangelo M, Cesario S (November 2019). "Update on the treatment of vitamin B6 dependent epilepsies". Expert Rev Neurother. 19 (11): 1135–47. doi:10.1080/14737175.2019.1648212. PMID 31340680. S2CID 198496085.
  48. Rosenberg IH (2012). "A history of the isolation and identification of vitamin B(6)". Ann Nutr Metab. 61 (3): 236–8. doi:10.1159/000343113. PMID 23183295. S2CID 37156675.
  49. György P (1934). "Vitamin B2 and the Pellagra-like Dermatitis in Rats". Nature. 133 (3361): 498–9. Bibcode:1934Natur.133..498G. doi:10.1038/133498a0. S2CID 4118476.
  50. György P, Eckardt RE (September 1940). "Further investigations on vitamin B(6) and related factors of the vitamin B(2) complex in rats. Parts I and II". The Biochemical Journal. 34 (8–9): 1143–54. doi:10.1042/bj0341143. PMC 1265394. PMID 16747297.
  51. "The Nobel Prize in Chemistry 1938". Nobelprize.org. Retrieved 5 July 2018.
  52. Harris SA, Folkers K (April 1939). "Synthetic vitamin B6". Science. 89 (2311): 347. Bibcode:1939Sci....89..347H. doi:10.1126/science.89.2311.347. PMID 17788439.
  53. "IUPAC-IUB commission on biochemical nomenclature (CBN). Nomenclature for vitamins B-6 and related compounds. Recommendations 1973". European Journal of Biochemistry. 40 (2): 325–327. 1973-12-17. ISSN 0014-2956. PMID 4781383.
  54. "Dietary Reference Values for vitamin B6". EFSA Journal. 14 (6): e04485. 2016. doi:10.2903/j.efsa.2016.4485. ISSN 1831-4732.
  55. Mocellin S, Briarava M, Pilati P (March 2017). "Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis". J Natl Cancer Inst. 109 (3): 1–9. doi:10.1093/jnci/djw230. PMID 28376200.
  56. Yang J, Li H, Deng H, Wang Z (2018). "Association of One-Carbon Metabolism-Related Vitamins (Folate, B6, B12), Homocysteine and Methionine With the Risk of Lung Cancer: Systematic Review and Meta-Analysis". Front Oncol. 8: 493. doi:10.3389/fonc.2018.00493. PMC 6220054. PMID 30430082.
  57. Fanidi, A; Muller, DC; Yuan, J; Stevens, VL; Weinstein, SJ (January 2018). "Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3)". Journal of the National Cancer Institute. 110 (1). doi:10.1093/jnci/djx119. ISSN 1460-2105. PMC 5989622. PMID 28922778.
  58. Johansson, M; Relton, C; Ueland, PM; Vollset, SE; Midttun, Ø (June 2010). "Serum B Vitamin Levels and Risk of Lung Cancer". JAMA. 303 (23): 2377–85. doi:10.1001/jama.2010.808. ISSN 0098-7484.
  59. Brasky TM, White E, Chen CL (October 2017). "Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort". Journal of Clinical Oncology. 35 (30): 3440–3448. doi:10.1200/JCO.2017.72.7735. ISSN 1527-7755. PMC 5648175. PMID 28829668.
  60. Calderon-Ospina, CA; Nava-Mesa, MO; Paez-Hurtado, AM (2020). "Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review". Therapeutics and Clinical Risk Management. 16: 1275–88. doi:10.2147/TCRM.S274122. ISSN 1176-6336. PMC 7764703. PMID 33376337.
  61. Jayedi A, Zargar MS (2019). "Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies". Crit Rev Food Sci Nutr. 59 (16): 2697–707. doi:10.1080/10408398.2018.1511967. PMID 30431328. S2CID 53430399.
  62. Zhang C, Luo J, Yuan C, Ding D (2020). "Vitamin B12, B6, or Folate and Cognitive Function in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis". J Alzheimers Dis. 77 (2): 781–94. doi:10.3233/JAD-200534. PMID 32773392. S2CID 221100310.
  63. Ford AH, Almeida OP (May 2019). "Effect of Vitamin B Supplementation on Cognitive Function in the Elderly: A Systematic Review and Meta-Analysis". Drugs Aging. 36 (5): 419–34. doi:10.1007/s40266-019-00649-w. PMID 30949983. S2CID 96435344.
  64. Wu Y, Zhang L, Li S, Zhang D (April 2021). "Associations of dietary vitamin B1, vitamin B2, vitamin B6, and vitamin B12 with the risk of depression: a systematic review and meta-analysis". Nutr Rev. doi:10.1093/nutrit/nuab014. PMID 33912967.
  65. Williams AL, Cotter A, Sabina A, Girard C, Goodman J, Katz DL (October 2005). "The role for vitamin B-6 as treatment for depression: a systematic review". Fam Pract. 22 (5): 532–7. doi:10.1093/fampra/cmi040. PMID 15964874.
  66. Li YJ, Li YM, Xiang DX (October 2018). "Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review". Eur J Nutr. 57 (7): 2571–82. doi:10.1007/s00394-017-1528-6. PMID 28884333. S2CID 3999214.
  • The B6 database A database of B6-dependent enzymes at University of Parma
  • Vitamin+B6 at the US National Library of Medicine Medical Subject Headings (MeSH)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.